VolitionRX Ltd
VNRX
Rank in Stocks
#31877
VolitionRx Limited, a multi-national epigenetics company, develops blood tests... VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Share Price
$0.2
Last synced: 2026-11-09
Market Cap
$2.41M
Change (1 day)
2.09%
Change (1 year)
-97.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade VolitionRX Ltd (VNRX)
Category
Healthcare
Operating Margin for VolitionRX Ltd (VNRX)
Operating Margin as of November 2026 TTM: -786.69%
According to VolitionRX Ltd's latest financial reports, its current operating margin (TTM) is -786.69%. At the end of 2025 the company had an operating margin of -1,228.57%.
Operating Margin history for VolitionRX Ltd from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -786.69% | -35.97% |
| 2025 | -1,228.57% | -43.92% |
| 2024 | -2,190.90% | -52.80% |
| 2023 | -4,641.76% | -55.25% |
| 2022 | -10,372.36% | -67.04% |
| 2021 | -31,468.96% | -80.11% |
| 2020 | -158,176.25% | 68.56% |
| 2019 | -93,840.22% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | -100.00% |
| 2014 | -40,158.37% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | -7,428.05% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.02% |
US
|
|
| 18.08% | -100.02% |
IE
|
|
| 21.25% | -100.03% |
US
|
|
| 21.05% | -100.03% |
US
|
|
| 28.09% | -100.04% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about VolitionRX Ltd's operating margin
What is VolitionRX Ltd's operating margin?
VolitionRX Ltd's operating margin is -786.69%, as of Nov 2026.
What was VolitionRX Ltd's operating margin in 2025?
In 2025, VolitionRX Ltd's operating margin was -1,228.57%, compared with -2,190.90% in 2024.
How has VolitionRX Ltd's operating margin changed since 2020?
From 2020 to 2025, VolitionRX Ltd's operating margin was highest in 2025 (-1,228.57%) and lowest in 2020 (-158,176.25%).
How does VolitionRX Ltd's operating margin compare with similar companies?
VolitionRX Ltd's operating margin (-786.69%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.